Lung Cancer

Expert-driven insights on lung cancer management across NSCLC and SCLC, highlighting evolving targeted therapies, immunotherapy strategies, and real-world treatment considerations. Focuses on treatment sequencing, CNS management, and emerging clinical data to support evidence-based care.

NSCLC

Browse all NSCLC

NSCLC

Ep. 3: Time Toxicity, CNS Risk, and Sequencing Strategy in EGFR-Mutant NSCLC

Eric Singhi, MD, Sarah Goldberg, MD, MPH, Fawzi Abu Rous, MD, Julia Rotow, MD, Susan Scott, MD

NSCLC

Ep. 2: Clinical Insights: Proactive Toxicity Management and CNS Control in EGFR-Mutant NSCLC

Eric Singhi, MD, Sarah Goldberg, MD, MPH, Susan Scott, MD, Fawzi Abu Rous, MD, Julia Rotow, MD

NSCLC

Ep. 3: Intensification Strategies and CNS Management in EGFR-Mutant NSCLC

Chinmay Jani, MD, Luis Raez, MD, FACP, FCCP, FASCO

NSCLC

Ep. 1: OS Benefit and Patient-Centered Delivery Advances in EGFR-Mutant NSCLC

Eric Singhi, MD, Susan Scott, MD, Sarah Goldberg, MD, MPH, Fawzi Abu Rous, MD, Julia Rotow, MD

SCLC

Browse all SCLC

SCLC

EP. 6: Key Takeaways From IMforte for Clinicians Treating ES-SCLC

Ticiana Leal, MD, Stephen Liu, MD, Isabel Preeshagul, DO, MBS, Rahul Gosain, MD, MBA, Rohit Gosain, MD

SCLC

EP. 5: Sequencing Lurbinectedin in ES-SCLC with CNS Involvement

Ticiana Leal, MD, Stephen Liu, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

SCLC

EP. 4: Managing Lurbinectedin Adverse Events in ES-SCLC Maintenance Therapy

Isabel Preeshagul, DO, MBS, Stephen Liu, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

SCLC

Ep. 3: Clinical Relevance of IMforte Survival Data in ES-SCLC

Ticiana Leal, MD, Stephen Liu, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD